{'fraction_non_alphanumeric': 0.022071307300509338, 'fraction_numerical': 0.013582342954159592, 'mean_word_length': 5.483516483516484, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
An animal model of transfusion‐related acute lung injury and the role of soluble CD40 ligand

Transfusion‐related acute lung injury (TRALI) is a life‐threatening complication of transfusion and is one of leading causes of transfusion‐associated fatalities. However, the pathogenesis of TRALI is still unclear. Soluble CD40 ligand (sCD40L) is a proinflammatory cytokine that accumulates during blood component storage and is involved in transfusion reactions. The objective of this study was to establish a clinically relevant TRALI animal model and to evaluate the role of sCD40L in TRALI.